Study of CBME in the Relief of Painful Diabetic Neuropathy

Status Completed

Clinical Trial Summary

The study is designed to investigate the benefit of adding CBME to the existing treatment regime in the management of painful neuropathy. Hypothesis: 1. The addition of CBME to the existing treatment regime will result in a significant improvement in both primary and secondary outcome measures. 2. The side effect profile and tolerability of CBME will be minimal and comparable to placebo.

Clinical Trial Description

1. To investigate the benefit of adding CBME to the existing treatment regime in the management of painful neuropathy. 2. To study the tolerability and side effect profile of CBME. 3. To study the effects of CBME treatment on vibration perception thresholds (VPT) and nerve conduction study parameters. 4. To evaluate the effects of CBME on central nervous system deep nuclei using MR Spectroscopy. ;

Study Design

Related Conditions & MeSH terms

Diabetic Neuropathies
Diabetic Neuropathy
Pain
Painful
Peripheral Nervous System Diseases

Clinical Trial Details

NCT number	NCT00238550
Study type	Interventional
Source	Sheffield Teaching Hospitals NHS Foundation Trust
Contact
Status	Completed
Phase	Phase 2
Start date	October 2003
Completion date	March 2006

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04025320` - The Effect of Intraneural Facilitation Therapy on Diabetic Patients With Peripheral Neuropathy	N/A
Completed	`NCT02659007` - Less Neuropathy After Yoga- Managing Diabetic Neuropathy With Yoga	Phase 1
Completed	`NCT01953757` - A Nutritional Intervention for Diabetic Neuropathy (WCCR-DN2)	N/A
Completed	`NCT01707979` - NIR- and Multifrequent Impedance Spectroscopy on the Skin in Type 1 Diabetes	N/A
Completed	`NCT00608439` - Centella Asiatica Selected Triterpenes (CAST) for Diabetic Neuropathy	Phase 2
Completed	`NCT00576277` - Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain	Phase 1/Phase 2
Completed	`NCT00830011` - Cognitive Behavioral Therapy for Painful Diabetic Neuropathy	N/A
Completed	`NCT00235443` - A Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Painful Distal Diabetic Neuropathy	Phase 2/Phase 3
Completed	`NCT00931879` - Lovaza® and Microvascular Function in Type 2 Diabetes	Phase 4
Completed	`NCT00190970` - The Effect of Ruboxistaurin on Small Fiber Function	Phase 2
Completed	`NCT00101426` - Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy	Phase 3
Completed	`NCT05573685` - Basket Study (CT-100-002) to Evaluate the Effects of a DiNaMo™ Component Training	N/A
Recruiting	`NCT02341261` - Activity for Diabetic Polyneuropathy	N/A
Completed	`NCT01822925` - Study of DA-9801 to Treat Diabetic Neuropathy	Phase 2
Completed	`NCT01690962` - A Nutritional Intervention for Diabetic Neuropathy	N/A
Terminated	`NCT00993018` - A Study of Effectiveness and Safety of JNJ-42160443 in Patients With Diabetic Painful Neuropathy	Phase 2
Withdrawn	`NCT02315235` - The Peripheral Mobilized Mononuclear Cell-based Therapy in Patient With Diabetic Neuropathy	N/A
Completed	`NCT00496457` - Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful Peripheral Diabetic Neuropathy	Phase 2
Recruiting	`NCT02606747` - The Balance Control Mechanism of DPN Patients	N/A
Completed	`NCT02068027` - Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy	Phase 2